Your browser is no longer supported. Please, upgrade your browser.
Settings
SNY [NASD]
Sanofi
Index- P/E9.04 EPS (ttm)5.71 Insider Own16.40% Shs Outstand2.51B Perf Week0.94%
Market Cap129.56B Forward P/E11.85 EPS next Y4.36 Insider Trans0.00% Shs Float2.25B Perf Month-1.32%
Income14.36B PEG1.21 EPS next Q0.75 Inst Own8.00% Short Float0.22% Perf Quarter-0.46%
Sales43.48B P/S2.98 EPS this Y324.80% Inst Trans0.11% Short Ratio3.66 Perf Half Y4.03%
Book/sh25.19 P/B2.05 EPS next Y16.28% ROA- Target Price63.88 Perf Year0.94%
Cash/sh- P/C- EPS next 5Y7.50% ROE- 52W Range44.76 - 54.26 Perf YTD6.26%
Dividend1.93 P/FCF- EPS past 5Y24.10% ROI14.20% 52W High-4.85% Beta0.56
Dividend %3.74% Quick Ratio- Sales past 5Y1.40% Gross Margin67.60% 52W Low15.35% ATR0.61
Employees99412 Current Ratio- Sales Q/Q-4.60% Oper. Margin23.30% RSI (14)45.89 Volatility0.95% 0.83%
OptionableYes Debt/Eq- EPS Q/Q-6.80% Profit Margin17.70% Rel Volume0.61 Prev Close51.86
ShortableYes LT Debt/Eq- EarningsJul 29 BMO Payout0.00% Avg Volume1.36M Price51.63
Recom1.00 SMA20-0.71% SMA50-1.88% SMA2003.24% Volume831,730 Change-0.44%
Jan-15-21Initiated Deutsche Bank Sell
Sep-29-20Initiated Berenberg Hold
Mar-17-20Upgrade Barclays Underweight → Equal Weight
Mar-11-20Upgrade Goldman Neutral → Buy
Feb-11-20Initiated SVB Leerink Mkt Perform
Jan-06-20Upgrade JP Morgan Neutral → Overweight
Sep-23-19Upgrade Guggenheim Neutral → Buy
Sep-20-19Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Nov-15-17Upgrade Barclays Underweight → Equal Weight
Jul-26-21 03:59PM  
11:45AM  
Jul-23-21 01:53PM  
Jul-22-21 02:36PM  
12:02PM  
Jul-21-21 01:43PM  
Jul-20-21 02:51PM  
Jul-19-21 02:01PM  
Jul-16-21 01:37PM  
Jul-15-21 02:58PM  
Jul-14-21 01:49PM  
06:30AM  
Jul-13-21 01:30AM  
Jul-12-21 03:09PM  
Jul-09-21 02:22PM  
Jul-08-21 01:57PM  
11:50AM  
11:45AM  
11:40AM  
09:19AM  
Jul-07-21 01:46PM  
11:47AM  
07:48AM  
Jul-06-21 02:30PM  
02:23PM  
02:21PM  
Jul-02-21 01:39PM  
08:06AM  
Jun-30-21 02:20PM  
01:42PM  
12:00PM  
Jun-29-21 10:22AM  
09:09AM  
04:16AM  
04:10AM  
04:00AM  
04:00AM  
Jun-28-21 08:00PM  
02:09PM  
12:40PM  
08:33AM  
02:00AM  
01:30AM  
01:00AM  
Jun-25-21 11:55AM  
08:51AM  
01:30AM  
01:15AM  
01:00AM  
Jun-24-21 02:00PM  
08:10AM  
Jun-23-21 01:48PM  
11:10AM  
Jun-22-21 09:01AM  
06:32AM  
Jun-21-21 02:44PM  
12:21PM  
Jun-20-21 05:11AM  
Jun-18-21 03:27PM  
02:04PM  
09:45AM  
06:37AM  
Jun-17-21 03:07PM  
12:33PM  
06:00AM  
Jun-16-21 04:42PM  
01:48PM  
11:49AM  
09:57AM  
Jun-15-21 03:20PM  
03:04PM  
Jun-14-21 08:00PM  
01:47PM  
Jun-11-21 02:31PM  
03:00AM  
Jun-10-21 08:00PM  
Jun-09-21 02:50PM  
Jun-08-21 02:03PM  
Jun-07-21 02:10PM  
01:45PM  
12:00PM  
Jun-04-21 02:50PM  
02:34PM  
02:12PM  
12:08PM  
10:11AM  
01:00AM  
Jun-03-21 01:36PM  
11:30AM  
08:00AM  
05:52AM  
Jun-02-21 02:15PM  
06:00AM  
01:44AM  
Jun-01-21 02:57PM  
11:26AM  
10:27AM  
08:54AM  
06:45AM  
01:00AM  
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration with TrialSpark Inc. to execute clinical research studies in the areas of chronic obstructive pulmonary disease. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerJul 28Buy16.0081,2501,300,000520,125Jul 29 06:06 AM